Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Metal binding to sodium valproate may be linked to hair loss in epilepsy patients.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Cladribine has known risks and potential new safety concerns, requiring careful monitoring.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

The nanocrystalline suspension effectively delivers dutasteride over time with minimal inflammation.

Extended-release divalproex is better tolerated and more effective for seizures and psychiatric symptoms than delayed-release divalproex, but doesn't reduce hair loss.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

Baricitinib may not always prevent relapse in alopecia areata.

Cinnamomi cortex may help treat prostate enlargement by reducing related proteins.

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

Switching to extended-release divalproex sodium improved patient-reported tremor but did not change seizure frequency or most side effects.

Removing certain brain receptors in mice worsens seizure severity and response to treatment during hormone withdrawal.

Intravenous cyclophosphamide effectively treated steroid-resistant lupus cystitis and peritonitis.

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Cyproterone acetate effectively treats virilized women, especially under 35, despite some side effects.

Thallium poisoning from contaminated cake caused severe health issues in Baghdad, highlighting the need to ban thallium as a rodenticide.

Maneb causes delayed hair follicle damage in rats.

Oral baricitinib is effective and safe for treating alopecia areata.

Clofazimine may be effective for treating ashy dermatosis.

Women with epilepsy on certain medications might gain weight and have higher thyroid-stimulating hormone levels, but not more polycystic ovarian syndrome.

Baricitinib is effective and safe for long-term treatment of severe alopecia areata.

IV cyclophosphamide effectively treated severe lupus nephritis in Indian patients, but longer follow-up is needed.

Reducing the dose of Baricitinib to 2mg still helped over half of the patients with severe scalp alopecia maintain their hair regrowth after two years.

Anionic squarticles can effectively counteract amitriptyline overdose, improving survival rates.

Some antiseizure medications can cause reversible hair loss, with valproate, lamotrigine, and carbamazepine being the most common.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.